chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my second Moderna booster for COVID-19 on 5/19/2022. On 7/25/2022, I had a little bit of a headache. My daughter tested positive for COVID-19 that day. On 7/26/2022, I had a more significant headache and underwent a PCR test, which yielded a positive result. Because of my history of asthma, I was prescribed PAXLOVID. Not only did I have a headache that day, but I also had a bit of nausea and an overall bodily feeling of something not being right. On 7/27/2022 and 7/28/2022, I was able to work from home, but on 7/28/2022, I had to stop working early, because I began to feel worse. I had a headache, dizziness, crushing fatigue, and a fever. At one point, the fever was at 100.4. I had also never been as fatigued in my life as I was during my bout of COVID-19. Starting on the mid-morning of 7/28/2022, I stayed in bed. On the night of 7/26/2022 or 7/27/2022, I had difficulty sleeping, because my breathing was obstructed by a large quantity of mucus in my sinuses; the mucus then settled in the back of my throat, which was not pleasant. During the night, I had a couple of episodes in which I found it hard to breathe because of this. It felt like someone had put a plug in my throat, and I was just gasping for air. It was very alarming. After I started taking the PAXLOVID, it felt like it kicked in quickly, because the symptoms didn't worsen, and they seemed to stabilize. The fever went away, and the mucus blockage and drainage abated. After that, I dealt mainly with headache and fatigue. I stayed in bed and just occasionally got up to use the toilet. Whenever I went to the toilet, my heart would start racing. On 8/1/2022, I took a home COVID-19 test, which yielded a negative result. I took a home test again on 8/3/2022 and 8/6/2022, and the results were negative both times. On about 8/4/2022, my isolation ended, though I made it a point to wear a mask around my family. I was still extremely fatigued and didn't return to work until 8/8/2022. During my time with COVID-19, I had major brain fog. I couldn't even concentrate well enough to read a novel. At the time of this writing, I feel that my mental function is gradually returning to normal and I am beginning to function at my pre-COVID level at work.
Flu vaccine received 11-16-06 at 11am.  11-17-06 woke up, eyes swollen, rash on throat. Saw ER physician 11-17-06 at 10 pm noted to have ?abscess above right eye, employee stated she had hit her head on cabinet at home in that spot 2 weeks before.
muscle weakness in arms and core muscles.  Unable to pick myself up to get out of bed for several hours
1 week post vaccine,  pain, redness, swelling, itching and heat in upper arm that was injected  Symptoms lasted for a week then diminished
Low grade fever under 100. Body aches. Fatigue. Still ongoing after 56 hours. Pain in arm.
worsening symptoms  cough and shortness of breath, generalized body aches and generalized weakness, sent from skilled nursing facility
low blood pressure; Pain in right leg; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (low blood pressure), PAIN IN EXTREMITY (Pain in right leg) and FATIGUE (Fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced HYPOTENSION (low blood pressure), PAIN IN EXTREMITY (Pain in right leg) and FATIGUE (Fatigue). At the time of the report, HYPOTENSION (low blood pressure), PAIN IN EXTREMITY (Pain in right leg) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
ErythemaMultiform, Diarrhea, 1 week following vaccine, redness and swelling, 3 days later (day 10) diarrhea. Narrative:
Patient was fully vaccinated against covid-19 and passed away on 11/26/2021.
Felt lethargy, aching, and tinnitus within hours of receiving shot. While other symptoms have gone away, the tinnitus has not.
Inadvertently administered influenza vaccine on 3/17/23 - resident had previously received influenza vaccine this influenza season  on 9/28/22.  MD and resident notified.  Post vaccine symptoms monitoring initiated.
pt recv vax; inconsolable crying for 6 hr, interrupted only by nap;thigh swollen w/ lump;family applied warm compresses & gave apap p/ 3 hr of crying which let pt sleep briefly; no exam done per family;
Information has been received from a medical assistant concerning an 83 year old female who on 30-OCT-2007 was vaccinated with PNEUMOVAX 23 (Lot #655500/1005F).  On 31-OCT-2007 the patient experienced injection site pain, swelling, redness, warmth and a blister.  As of 31-OCT-2007, the patient had not recovered.  Additional information has been requested.
Initial symptoms numbeness and tingleness in mouth anf face; hour after vaccine both hands dark blue
Menstrual cycle started on 9.7.21; 1 week early for an otherwise normal cycle. Previous cycle was 8.16.21. Menstrual cycle started again 10.1.21, only 3 weeks after previous cycle start date. Again, this is an abnormality that did not exist prior to 2nd vaccine. October 2021 cycle is also abnormally heavy and consisting of clots.
clots/Clot blood; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An elderly male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THROMBOSIS (medically significant), outcome "unknown", described as "clots/Clot blood". Clinical course: Patient/consumer details: Age: 50-99. The reporter considered event as caused by suspect product. The first Pfizer shots gave him clots.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
the patient needed her 3rd dose of Engerix-B but she refused to get it; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Engerix B (1st dose received on an unknown date) and Engerix B (2nd dose received on an unknown date).   On an unknown date, the patient did not receive the 3rd dose of Engerix B and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Linked case(s) involving the same patient: US2022146845, US2022AMR148351   Additional Information: GSK Receipt Date: 12-Oct-2022 Reporter's comment: The registered nurse stated that she had Havrix and Engerix-B prefilled syringes that she placed needles on but the patient changed her mind.  The reporter asked how long were they stable.  The nurse probed and she stated that the patient changed her mind because she had too many Hepatitis A vaccines (4 or 5) because she kept missing the recommended intervals for the doses and her health-care professional thought she needed to get additional doses everytime.  The health-care professional mentioned that the patient was from out of the country and could not provide any information on if the vaccines were Havrix or another Hepatitis A series.  The health-care professional mentioned that the patient needed her 3rd dose of Engerix-B but she refused to get it.  The health-care professional declined to provide any patient information and did not had any vaccine information as the doses were not administered at their facility.  The health-care professional also declined follow up. The reporter did not consent to follow-up. This case was linked with case US2022AMR148351 and US2022146845, reported by the same reporter. Additional Supportive Information: Till the time of reporting, the patient did not receive 3rd dose of Engerix B, which led to incomplete course of vaccination.; Sender's Comments:  US-GSK-US2022AMR148351:Same reporter US-GSK-US2022146845:Same reporter
Developed a headache and soreness in arm that evening.  Headache continued to worsen each day and never went away until I woke up one morning in April (Saturday the 10th) and then realized I was headache free.  I suffered with migraines until my late 20's so I know the difference between types of headaches and this one was a borderline migraine that was 24/7 for nearly 2-months straight. The part that I'm righting about of most concern was 4 days after my 2nd shot (Saturday, 02/20/2021) I was working in the yard and the headache was unbearable.  I started to sweat profusely and felt nauseous.  As I quickly walked inside to the bathroom I felt like I had to have an emergency bowel movement as well.  Made it to the bathroom and took care of business, but my headache became excruciating painful at the base of my skull and i passed out onto the bathroom floor.  Major hot flashes, profuse sweating when my wife shook me to.  Had her help me to the pool where I got into a cold pool to try and lower any temps and hot flashes.  That helped a lot.  Then made it to my chair where I stayed covered up shivering the rest of the day.  All I tool was 6 chewable baby aspirin that I let dissolve in my mouth and slowly washed down with ginger ale.  I tool the aspirin for the headache and erratic hear beat / palpitation's.
pregnant patient who was due for a dose of Menactra with no reported adverse event; Initial information with live follow up received on 25-Mar-2021 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a female patient of unknown age who was due for a dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (exposure during pregnancy).  The date of last menstrual period was not reported.  The estimated due date was not reported (unknown).  Medical history, past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications were not reported.  On an unknown date, the patient received an unknown dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot number: unknown and expiration date: unknown) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, pregnant patient who was due for a dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (exposure during pregnancy).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was not applicable.  There will be no information available regarding batch number in this case.
my arm felt sore; sudden intestinal attacks; headache; sore throat; laryngitis; body very jittery; tired; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a 10-year-old patient who received DTPa (Reduced antigen) (dTpa vaccine) for prophylaxis.   Previously administered products included Tetanus vaccine (Received tetnus vaccine on unknown date).   In June 2021, the patient received dTpa vaccine. On an unknown date, 1 day after receiving dTpa vaccine, the patient experienced pain in arm, gastrointestinal disorder, headache, sore throat, laryngitis, feeling jittery and tiredness. On an unknown date, the outcome of the pain in arm, gastrointestinal disorder, headache, sore throat, laryngitis, feeling jittery and tiredness were recovered/resolved.   It was unknown if the reporter considered the pain in arm, gastrointestinal disorder, headache, sore throat, laryngitis, feeling jittery and tiredness to be related to dTpa vaccine.  Additional details were provided as follows: The case was reported by the patient himself/herself. The patient received the dose of Tetanus vaccine in past and patient did not remember side effects. The patient received the booster dose for Tetanus, Diphtheria and Pertussis last month of reporting date and 2nd day the patient experienced sore arm and the 3rd day patient did not have fever but had sudden intestinal attacks,headache,sore throat,laryngitis,body was very jittery and tired for two weeks The reporter stated that the side effects were horrible for two weeks and he/she was glad that was over.
This spontaneous report as received from a health care worker refers to a 18 year old female patient. On an unknown date in the beginning of January 2011, the patient who was vaccinated with a first dose of GARDASIL (Lot number and expiry date was not reported), received the second dose on 29-OCT-2012 and the third dose of GARDASIL (Lot number H016238 and expiry date was 11-APR-2014) 0.5 milliliter (ml) intramuscularly on 03-JAN-2013. No adverse events reported. Additional information has been requested.
About 2 weeks after the 2nd vaccine I began to develop hives on my arms, legs, stomach, hips, and buttocks. They usually appeared in the between 8pm and 2am. I took Benadryl and they would subside in about 12 hours. This has continued to occur o n a daily basis. I have not changed anything in my diet or changed any product that comes in contact with my body,
No adverse event; on unspecified date an unspecified number of patients were administered improperly stored PEDVAXHIB, ROTATEQ, and VAQTA; This spontaneous report was received from a medical assistant referring to a 6-months-old male patient. The patient's medical history, concurrent condition and concomitant medication were unknown.  On 07-NOV-2019, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) of lot # S004398 with expiration date 31-OCT-2020 (strength, dose, dose number and route of administration were unknown) for prophylaxis (product storage error).   On an unknown date, the vaccine was stored at a temperature above 47 degrees Fahrenheit/9 degrees Celsius (9.3 Celsius (C)) for 23 minutes. Previous temperature excursion was at a temperature above 47 degrees Fahrenheit/9 degrees Celsius (8.7 C) for 36 minutes, 47 degrees Fahrenheit/9 degrees Celsius (8.9 C) for 15 minutes and 47 degrees Fahrenheit/9 degrees Celsius (9 C) for 12 minutes. Digital data logger was involved. No adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1910USA012749:
upper arm started itching; Hard; Injection site red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (upper arm started itching), VACCINATION SITE REACTION (Hard) and VACCINATION SITE ERYTHEMA (Injection site red) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CEFALEXIN (KEFLEXIN) for an unknown indication.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (upper arm started itching), VACCINATION SITE REACTION (Hard) and VACCINATION SITE ERYTHEMA (Injection site red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) on 08-Jan-2021 for Rash, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (upper arm started itching), VACCINATION SITE REACTION (Hard) and VACCINATION SITE ERYTHEMA (Injection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: This case concerns a 64-year-old female who experienced nonserious events of unexpected injection site reaction, injection site pruritus and expected injection site erythema.  Event onset occurred 8 days after the first dose of mRNA-1273. Treated with Keflex. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Thirteen days after receiving her second varicella vaccination, she developed a papular rash on her bottom and lower back. Mom reported less than 50 lesions. Rash lasted 5 days. Child was diagnosed with varicella over the phone. Rash was never observed by a healthcare provider.
Suspected Vaccination Failure; had the shots and I still got shingles; This case was reported by a consumer via interactive digital media  and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was reported by patient himself or herself. The age at vaccination was not reported. The patient had the shots and still got shingles.  The patient's doctor said it was mild case because the patient had the shots. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles were not provided.
Pt presents following syncopal episode 5 minutes post vaccination of 1 dose Janssen vaccine to right deltoid. Pt?s wife states that he was sitting in the car when he started to complain of dizziness, lightheadedness, and nausea followed by +LOC x1 minute. He had no head injury or other trauma. On immediate evaluation he is conscious and endorses nausea and lightheadedness. He denies medical problems, medications, or any Hx of allergies. He states that he has syncopized multiple times in the past after getting vaccines and giving blood. He also states that he was nervous to get the vaccine today. Pt denies swelling of the face, throat tightness, difficulty swallowing, itching of the skin, SOB, or CP. Following repeat vital signs that showed improved sitting BP of 113/70, Pt refused medical transport and signed out AMA with EMS. Pt was driven home by his wife.
Became sick, dizzy throwing up, Kidney hurting. Went to doctor was sent to hospital was found to have enlarged prostate. Then had a lump come up under left arm same arm shot was given and was told my lymph nodes were swollen.
Soreness of upper arm, progressively worsening since vaccination, especially w/movement, state pain, 6-7/10.
Early Sunday 5/9, she was sore all over her body, achy, injection site was hot to the touch with red ring.  Symptoms started to subside on Monday 5/10/21
PATIENT IMMEDIATELY HAD A SWOLLEN ARM.  WAS OFFERED BENADRYL AND/OR EPIPEN. SHE DECLINED BOTH. NO ICE PACKS WERE AVAILABLE. KEPT THE PATIENT UNDER OBSERVATION FOR 10-20 MINUTES.  SHE SAID SHE FELT FINE AND LEFT
Instead of being given 0.1ml of PPD, patient was administered 0.1ml of fluzone
Patient states that from 7-4-16 to 7-11-16 they had a skin rash all over their back, chest, thighs, and arms. Patient states that they had an intense scratching/ burning sensation on their skin and that their skin was bumpy. Patient reported on 7/20/16 that they may have an allergy to a certain IV medication but they did not know what the product was. It could be a potential latex allergy, however the vials of Havrix do not have any Latex.
Patient experienced dizziness and nerve pain up and down the spine and neck, as well as in her hands and feet since receiving the vaccine.  This started later in the day on the same day she received vaccination and has continued since.
After receiving the first dose I went through the typical symptoms that were mentioned.  I had muscle aches, tiredness, and soreness.  That lasted about a day and was back to normal in two days.  On the 5th day after getting my shot I woke up to extreme pain in my left shoulder (dose 1 injection site).  I could pinpoint exactly where the needle must have gone in, because that area was the most painful.  I had full mobility of the shoulder but moving it would increase the pain substantially.  This extreme pain lasted about two weeks.  It took about a month for the constant pain to go away.  I now experience days where I can feel tightness and light pain in the shoulder at the point of injection.  It is nothing serious and usually goes away overnight.  This occurs at least once every few weeks.
Expired vaccine administered to 14 patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 14 patients) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.No Medical History information was reported.On 12-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 14 patients). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 14 patients) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.Concomitant medication information was not reported. Treatment information was not reported.This is a case of Expired Product Administered concerning a 56-year-old male patient with no relevant medical history, who experienced no other adverse events. The event occurred the same day after receiving an unknown dose number of mRNA-1273 Vaccine. The rechallenge was unknown since no dose number was disclosed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. This case was linked to MOD-2021-350795 (Patient Link). Sender's Comments: This is a case of Expired Product Administered concerning a 56-year-old male patient with no relevant medical history, who experienced no other adverse events. The event occurred the same day after receiving an unknown dose number of mRNA-1273 Vaccine. The rechallenge was unknown since no dose number was disclosed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
"Moderna Arm" aka "Covid Arm"- began on April 6, late afternoon with itching, on the 8th day after my 1st dose.  I soon  realized it had been itching a LOT and I felt where  I was itching through my shirt that it was raised, so I looked and saw there was a large circle of raised reddish- pink irregular circle around the shot site.  I applied Benadryl cream after a few hours and I stopped scratching. I also took oral Benadryl and my regular Allegra.  From what I saw online, my Covid Arm was milder and smaller in width than pictures of "Moderna Arm"  I saw online. The raised area and the pinkness was  gone by Friday April 9th, although it still occasionally itches mildly.